Brielle Benyon is an Assistant Managing Editor at CURE Media Group, OncLive, and Oncology Nursing News. With a focus on oncology and healthcare, Brielle's articles cover a wide range of topics including patient experiences, medical advancements, clinical trials, and the impact of cancer on various aspects of life. She is dedicated to providing informative and supportive content to those affected by cancer.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Brielle Benyon's coverage focuses heavily on healthcare and pharmaceutical topics, particularly in the field of oncology. The articles she covers often include data citations and expert commentary, indicating a strong emphasis on evidence-based reporting.
Given this focus, Brielle would likely be responsive to pitches from experts in the fields of oncology, cancer treatment, clinical trials, breast cancer research, and MPNs (Myeloproliferative Neoplasms). Sources with access to recent data or those who can provide insightful commentary based on evidence are also likely to resonate well with her.
As there is no specified geographic focus for Brielle's coverage area, relevant information or expertise from any location could be suitable for pitching.
This information evolves through artificial intelligence and human feedback. Improve this profile .
October 29, 2024 By Brielle Benyon Fact checked by Kristie L. Kahl
By: Brielle Benyon, Alex Biese
The FDA granted an accelerated approval to asciminib for newly diagnosed Ph+ chronic myeloid leukemia in the chronic phase.
By: Brielle Benyon
A nurse practitioner discusses how breast cancer treatment can impact sexual health, and how nurses and APPs can guide patients through these effects.
By: Brielle Benyon
With newer breast cancer treatments, it’s essential that nurses and APPs educate themselves and advocate for their patients.
By: Brielle Benyon, Alex Biese
An ad-hoc analysis found a higher rate of severe and life-threatening infections in patients with RET-mutant lung cancer treated with pralsetinib.
By: Brielle Benyon, Ashley Chan
With many patients utilizing medical cannabis, it is important for nurses to be aware of potential drug-drug interactions, an expert said.
By: Brielle Benyon, Ashley Chan
Topical treatments may help ease chemotherapy-induced peripheral neuropathy, but more research is needed.
By: Brielle Benyon, Ashley Chan
At a recent Community Case Forum, an expert discussed the risk of cytokine release syndrome after patients undergo CAR T-cell therapy.
November 20, 2024 By Brielle Benyon Fact checked by Kristie L. Kahl
By: Brielle Benyon, Ashley Chan
Oncology nurses “play a pivotal role in guiding patients” through the genetic testing process, an expert explained.
(833) 317-6278 
